Anti-Tuberculosis
Journal:
Current Bioactive Compounds
Volume:
1
Page:
53-53
Author(s):
Bentham Science Publishers
Oxidative Stress in the Molecular Mechanism of Pathogenesis at Different Diseased States of Organism in Clinics and Experiment
Journal:
Current Drug Targets - Inflammation & Allergy
Volume:
4
Page:
85-98
Author(s):
Konstantin G. Karageuzyan
MEFV Mutation Carriers and Diseases Other than Familial Mediterranean Fever: Proved and Non-Proved Associations; Putative Biological Advantage
Journal:
Current Drug Targets - Inflammation & Allergy
Volume:
4
Page:
105-112
Author(s):
Daniel Cattan
Pulmonary Tuberculosis in Various Gene Knockout Mice With Special Emphasis on Roles of Cytokines and Transcription Factors
Journal:
Current Respiratory Medicine Reviews
Volume:
1
Page:
7-13
Author(s):
Isamu Sugawara, Hiroyuki Yamada and Ruiru Shi
Identification and Validation of Novel Drug Targets in Tuberculosis
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
3185-3194
Author(s):
K. Duncan
Structural Bioinformatic Approaches to the Discovery of New Antimycobacterial Drugs
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
3195-3211
Author(s):
Katherine Kantardjieff and Bernhard Rupp
Fluoroquinolones as Chemotherapeutics Against Mycobacterial Infections
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
3213-3220
Author(s):
Michael R. Jacobs
In Vitro and In Vivo Activities of New Rifamycin Derivatives Against Mycobacterial Infections
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
3229-3238
Author(s):
N. Lounis and G. Roscigno
Prospects for Clinical Introduction of Nitroimidazole Antibiotics for the Treatment of Tuberculosis
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
3239-3262
Author(s):
Clifton E. Barry, Helena I.M. Boshoff and Cynthia S. Dowd
Microsphere Technology for Chemotherapy of Mycobacterial Infections
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
3275-3284
Author(s):
William W. Barrow